Diadema Partners »

Bioage Labs shares owned by Diadema Partners

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9M 294k 13.23

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Bioage Labs

AH Capital Management
Sofinnova Ventures
Cormorant Asset Management
Octagon Capital Advisors
BlackRock
Vanguard Group
OrbiMed Advisors
Sands Capital Ventures
Pivotal bioVenture Partners Investment Advisor
Geode Capital Management
Cosmic Management
State Street Corporation
Redpoint Management
Jacobs Levy Equity Management
Millennium Management

View all funds holding Bioage Labs